Plus: Germany foils an alleged Russian act of sabotage. And Novo Nordisk strikes a $2.2 billion deal to develop obesity pills with U.S. biotech Septerna.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices